Alten Logo

Alten

ATE | PA

Overview

Corporate Details

ISIN(s):
FR0000071946 (+29 more)
LEI:
969500Y7G9TY7Y24GN07
Country:
France
Address:
40 AVENUE ANDRE MORIZET, 92100 BOULOGNE-BILLANCOURT
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Alten is a global leader in technology consulting, engineering, and IT services. The company specializes in outsourced engineering, research and development (R&D), and IT solutions, supporting the technological and digital transformation of its clients. Its engineers and consultants undertake complex, high-tech projects across the entire value chain for leading companies in the industrial, telecommunications, and service sectors. Services include design and research, software development, IoT integration, data analytics, and cybersecurity. With over 30 years of experience and more than 57,000 employees operating in over 30 countries, Alten delivers its expertise through various models, including project-based contracts and consulting services.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Alten. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-07 17:45
Declaration of Voting Results & Voting Rights Announcements
July 2025
English 252.0 KB
2025-08-07 17:45
Declaration of Voting Results & Voting Rights Announcements
Juillet 2025
French 175.3 KB
2025-06-06 17:45
Share Issue/Capital Change
May 2025
English 251.9 KB
2025-06-06 17:45
Declaration of Voting Results & Voting Rights Announcements
Mai 2025
French 251.9 KB
2025-05-22 17:50
Pre-Annual General Meeting Information
Communiqué de mise à disposition des documents préparatoires - Assemblée Généra…
French 178.2 KB
2025-05-22 17:50
Pre-Annual General Meeting Information
Press release relating to the availability of the preparatory documents - GM to…
English 191.4 KB
2025-05-07 17:45
Declaration of Voting Results & Voting Rights Announcements
April 2025
English 251.5 KB
2025-05-07 17:45
Declaration of Voting Results & Voting Rights Announcements
Avril 2025
French 252.0 KB
2025-04-25 18:00
Registration Form
Availability of the 2024 universal registration document
English 249.7 KB
2025-04-25 18:00
Registration Form
Modalités de mise à disposition du document d’enregistrement universel 2024
French 251.7 KB
2025-04-25 15:44
Annual Report (ESEF)
Document d'enregistrement universel 2024
French 23.9 MB
2025-04-25 10:50
Earnings Release
Erratum only on the press release in English: First quarter 2025 revenue
English 235.4 KB
2025-04-24 17:40
Pre-Annual General Meeting Information
Communiqué relatif à la convocation de l'Assemblée Générale 2025 et au dividend…
French 245.6 KB
2025-04-24 17:40
Notice of Dividend Amount
Press release relating to the 2025 General Meeting and to the 2024 Dividend
English 234.4 KB
2025-04-24 17:40
Earnings Release
GROUPE ALTEN : Activité du premier trimestre 2025
French 215.4 KB

Automate Your Workflow. Get a real-time feed of all Alten filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Alten via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-09-22 N/A Other Sell 620 77,748.00 EUR
2023-07-04 N/A Other Sell 850 119,255.00 EUR
2023-06-26 N/A Other Sell 750 103,350.00 EUR
2023-06-18 N/A Other Buy 5,000 N/A
2023-04-28 N/A Other Sell 4,144 644,148.75 EUR
2023-04-27 N/A Other Sell 856 132,680.00 EUR
2023-02-23 N/A Other Buy 5,000 N/A

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN